Literature DB >> 15042317

Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands.

Nils Milman1, Torkil á Steig, Pernille Koefoed, Palle Pedersen, Kirsten Fenger, Finn Cilius Nielsen.   

Abstract

The aim of the study was to assess the frequencies of the hereditary hemochromatosis HFE mutations C282Y, H63D, and S65C in the population in the Faroe Islands. The series comprised 200 randomly selected blood donors of Faroese heritage. The frequency of the C282Y, H63D, and S65C mutations on the HFE gene was assessed by genotyping using the polymerase chain reaction (PCR) technique and calculated from direct allele counting. We found no C282Y homozygous subjects; 28 (14.0%) subjects were C282Y heterozygous and four subjects were C282Y/H63D compound heterozygous (2.0%). The C282Y allele frequency was 8.0% (95% CI 5.3-10.7%). The series contained three (1.5%) H63D homozygous subjects and 60 (30.0%) H63D heterozygous subjects. The H63D allele frequency was 17.5% (95% CI 13.8-21.2%). There were four (2.0%) S65C heterozygous subjects. The S65C allele frequency was 1.0% (95% CI 0.3-2.5%). The frequency of the C282Y mutation is high in Faroese blood donors, being close to and not significantly different from the frequencies reported in other Scandinavian countries: Denmark 5.7%, Norway 6.6%, Iceland 5.1%, and Sweden 6.1%. The frequency of the H63D mutation in Faroese subjects is significantly higher than the frequency in Denmark 12.8% (p=0.007), Iceland 10.9% (p=0.003), and Sweden 12.4% (p=0.015), but not from the frequency in Norway 11.2% (p=0.063). The frequency of the S65C mutation in Faroese subjects is not significantly different from the frequencies in Denmark 1.5% and Sweden 1.6%. Screening of larger groups of the Faroese population for HFE mutations especially C282Y should be considered in order to establish the penetrance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15042317     DOI: 10.1007/s00277-004-0865-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  5 in total

1.  Analysis of HFE genes C282Y, H63D, and S65D in patients with hyperferritinemia from northeastern Brazil.

Authors:  Gioconda Dias Rodrigues Leão; Juliana Mendonça Freire; Andrea Luciana Araújo Cunha Fernandes; Taissa Maria Moura de Oliveira; Nilma Dias Leão; Erica Aires Gil; Roberto Chaves de Vasconcelos; João Paulo da Silva Azevedo; Valéria Soraya de Farias Sales; Telma Maria de Araújo Moura Lemos; Marcos Dias Leão; Francisco Fernandes do Nascimento; James Farley Rafael Maciel; Rodrigo Villar de Freitas; Aldair de Souza Paiva; Geraldo Barroso Cavalcanti
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

2.  Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.

Authors:  Jónrit Halling; Maria S Petersen; Per Damkier; Flemming Nielsen; Philippe Grandjean; Pál Weihe; Stefan Lundgren; Mia Sandberg Lundblad; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2005-07-16       Impact factor: 2.953

3.  Prevalence of 845G>A HFE mutation in Slavic populations: an east-west linear gradient in South Slavs.

Authors:  Grazyna Adler; Jeremy S Clark; Beata Łoniewska; Andrzej Ciechanowicz
Journal:  Croat Med J       Date:  2011-06       Impact factor: 1.351

4.  Semen quality and reproductive hormones in Faroese men: a cross-sectional population-based study of 481 men.

Authors:  Jónrit Halling; Maria Skaalum Petersen; Niels Jørgensen; Tina Kold Jensen; Philippe Grandjean; Pál Weihe
Journal:  BMJ Open       Date:  2013-03-01       Impact factor: 2.692

5.  The evolutionary adaptation of the C282Y mutation to culture and climate during the European Neolithic.

Authors:  Kathleen M Heath; Jacob H Axton; John M McCullough; Nathan Harris
Journal:  Am J Phys Anthropol       Date:  2016-01-22       Impact factor: 2.868

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.